Aytu reports first full launch quarter for EXXUA, fiscal 2026 results
EXXUA brought in $3.9 million in fourth-quarter net revenue and $6.6 million for the fiscal year, while legacy ADHD and pediatric brands declined amid generic competition.
SEC filing